Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 6
Submit an article Journal homepage
48
Views
13
CrossRef citations to date
0
Altmetric
Primary Research

Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries

Anna Bucsics Hauptverband der Österreichischen Sozialversicherungsträger, Kundmanngasse 21, A-1031 Wien, Austria
,
Brian Godman Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. [email protected]; Mario Negri Institute for Pharmacological Research, Via Giuseppe La Masa 19, 20156 Milan, Italy; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, UK; Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. [email protected]; Mario Negri Institute for Pharmacological Research, Via Giuseppe La Masa 19, 20156 Milan, Italy; Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, UK
,
Thomas Burkhardt Hauptverband der Österreichischen Sozialversicherungsträger, Kundmanngasse 21, A-1031 Wien, Austria
,
Manuela Schmitzer Hauptverband der Österreichischen Sozialversicherungsträger, Kundmanngasse 21, A-1031 Wien, Austria
&
Rickard E Malmström Department of Medicine, Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Solna, Stockholm, Sweden
Pages 809-819 | Published online: 09 Jan 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kristina Garuolienė, Brian Godman, Jolanta Gulbinovič, Krijn Schiffers & Björn Wettermark. (2016) Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 149-152.
Read now
Wenjie Zeng, Lars L Gustafsson, Marion Bennie, Alexander E Finlayson & Brian Godman. (2015) Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 15:1, pages 157-169.
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now

Articles from other publishers (10)

Georg Heinze, Milan Hronsky, Berthold Reichardt, Christoph Baumgärtel, Marcus Müllner, Anna Bucsics & Wolfgang C. Winkelmayer. (2014) Potential Savings in Prescription Drug Costs for Hypertension, Hyperlipidemia, and Diabetes Mellitus by Equivalent Drug Substitution in Austria: A Nationwide Cohort Study. Applied Health Economics and Health Policy 13:2, pages 193-205.
Crossref
James C. Moon, Brian Godman, Max Petzold, Samantha Alvarez-Madrazo, Kathleen Bennett, Iain Bishop, Anna Bucsics, Ulrik Hesse, Andrew Martin, Steven Simoens, Corinne Zara & Rickard E. Malmström. (2014) Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Frontiers in Pharmacology 5.
Crossref
Wenjie Zeng, Junjie Zhen, Mengying Feng, Stephen M Campbell, Alexander E Finlayson & Brian Godman. (2014) Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction. Journal of Comparative Effectiveness Research 3:4, pages 371-386.
Crossref
Thirimon Moe-Byrne, Duncan Chambers, Melissa Harden & Catriona McDaid. (2014) Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review. BMJ Open 4:5, pages e004623.
Crossref
Ana Luísa Caires de Souza, Francisco de Assis Acurcio, Augusto Afonso Guerra Júnior, Renata Cristina Rezende Macedo do Nascimento, Brian Godman & Leonardo Maurício Diniz. (2014) Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review. Applied Health Economics and Health Policy 12:1, pages 19-32.
Crossref
Ulrik Hesse, Brian Godman, Max Petzold, Andrew Martin & Rickard E. Malmström. (2013) Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries. Applied Health Economics and Health Policy 11:6, pages 677-685.
Crossref
Brian Godman, Kristien De Bruyn, Jamilette Miranda, Emanuel Raschi, Marion Bennie, Corrado Barbui & Steven Simoens. (2013) Generic atypical antipsychotic drugs in Belgium: their influence and implications. Journal of Comparative Effectiveness Research 2:6, pages 551-561.
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Corrado Barbui, Marion Bennie, Alexander E Finlayson, Emanuel Raschi & Bjorn Wettermark. (2013) Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications. Journal of Pharmaceutical Health Services Research 4:3, pages 139-150.
Crossref
Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström & Brian Godman. (2013) Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future. Journal of Pharmaceutical Health Services Research 4:3, pages 173-181.
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Peter Skiöld, Björn Wettermark, Corrado Barbui & Lars L. Gustafsson. (2013) Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden. Applied Health Economics and Health Policy 11:4, pages 383-393.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.